A Prospective Analysis of Vasoreactivity and Mortality in WHO Group 3 Pulmonary Hypertension

ABSTRACT Prognostic markers of Group 3 pulmonary hypertension (PH) remain largely unknown. In this study, we evaluate clinical data to provide a comprehensive profile of patients with Group 3 PH and evaluate the potential use of vasoreactivity testing as a prognostic tool within this population. We...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel J. Strick, Carl Tanba, Meredith A. Kaplan, Nicholas S. Hill, Harrison W. Farber, David Condon, Ioana R. Preston
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Pulmonary Circulation
Subjects:
Online Access:https://doi.org/10.1002/pul2.70078
Tags: Add Tag
No Tags, Be the first to tag this record!